Menu
Live News EQUITY M impact

APGE Downgraded

Deutsche Bank downgrades Apogee Therapeutics to Hold and raises price target to $135

APGE

Deutsche Bank Downgrades Apogee Therapeutics to Hold, Raises Price Target to $135